LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Kashuba and Marx Join Cerepedics
People In The News

Kashuba and Marx Join Cerepedics

June 3, 2013 1 min read Premium comments

Advertisement

Kashuba and Marx Join Cerepedics
Top Image: Glen A. Kashuba / Bottom Image Jeffrey G. Marx, Ph.D.:

Cerepedics, Inc., a company located in Westminster, Colorado, that specializes in osteobiologic products based upon its synthetic small peptide technology platform, has added two new executives to its administrative roster. One is Glen A. Kashuba who is the firm’s new chief executive officer. The second is Jeffrey G. Marx, Ph.D., who is the new president and chief operating officer.

Kashuba formerly served as president of Spine & Bone Healing Technologies, Inc., a Biomet company, while concurrently serving as senior vice president on Biomet’s worldwide operating board. The position encompassed Biomet’s orthopedics, spine, trauma, biologics and sports medicine businesses. While at Biomet, Kashuba had profit and loss responsibility for all functional areas for Biomet Spine and Trauma including sales force management and supply chain optimization. His commercial responsibilities included managing sales of greater than $400 million, driven by more than 500 direct and independent sales representatives. Kashuba was responsible for launching more than 25 new products into the market during his tenure.

Prior to his role at Biomet, Kashuba held a number of division president jobs at Johnson & Johnson where he served as worldwide president for Cordis Endovascular and Neurovascular and as president for Codman Neuro Sciences. Kashuba was also the U.S. president for DePuy Spine. He received his B.S. in industrial engineering from Rutgers University and succeeds Paul Mraz, who has announced his intention to retire from the company.

Jeffrey Marx formerly served as vice president of corporate development at Orthovita, Inc. He had numerous other responsibilities as part of the senior leadership team during his 13-year tenure. Orthovita was a leading orthobiologics and biosurgery company that Stryker acquired for $318 million in 2011.

Following the acquisition, Marx led the integration of Orthovita into Stryker and served as vice president of corporate development at Stryker Orthobiologics. He received his B.S. in ceramic science and engineering from Penn State University and his Ph.D. in ceramic engineering from Missouri University of Science and Technology.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy